Florou, Vaia; Rosenberg, Andrew E; Wieder, Eric; Komanduri, Krishna V; Kolonias, Despina; Uduman, Mohamed; Castle, John C; Buell, Jennifer S; Trent, Jonathan C; Wilky, Breelyn A

doi:10.1186/s40425-019-0792-9

Download PDF

Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

2019

Published Web Location

https://doi.org/10.1186/s40425-019-0792-9

Abstract

Following publication of the original article [1], the authors have reported that the following sentence "While of the same IgG1 class as ipilimumab, preclinical data suggests this molecule may have enhanced activity against T regulatory cells".

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content

For improved accessibility of PDF content, download the file to your device.

UCSF

Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

Published Web Location